Lefèvre, Gilbert <br/><br/>
Pharmacokinetics and bioavailability of the novel rivastigmine transdermal patch versus rivastigmine oral solution in healthy elderly subjects.  [electronic resource] 

 -  Journal of clinical pharmacology  Feb 2008 
 - 246-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Standard No.: </label>10.1177/0091270007312154  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Administration, Oral<br/>Aged--physiology<br/>Area Under Curve<br/>Benzylamines--blood<br/>Biological Availability<br/>Cholinesterase Inhibitors--administration & dosage<br/>Chromatography, High Pressure Liquid<br/>Cross-Over Studies<br/>Dizziness--chemically induced<br/>Female<br/>Half-Life<br/>Headache--chemically induced<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Nausea--chemically induced<br/>Phenethylamines<br/>Phenols--blood<br/>Phenylcarbamates--blood<br/>Rivastigmine<br/>Sleep Initiation and Maintenance Disorders--chemically induced<br/>Solutions<br/>Tandem Mass Spectrometry<br/>Vomiting--chemically induced